3 recruiting. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 3 |
Follow Interviews as Topic: new trials by email Literature Review of Interviews as Topic trials Research Report on Interviews as Topic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung Cancer Biospecimen Collection, Counseling, Interview - Lung Non-Small Cell Carcinoma, Unipolar Depression | Phase 2 | Recruiting | Alan Davis | 10 | 2026-01-01 | 2026-05-14 |
| Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population Celecoxib, Erlotinib Hydrochloride, Imaging Procedure - Metastatic Oral Cavity Carcinoma, Recurrent Oral Cavity Carcinoma | Phase 2 | Recruiting | Mayo Clinic | 25 | 2025-08-07 | 2026-10-01 |
| A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study Discussion, Goal Setting, Interview - Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm | Phase 2 | Recruiting | Children's Oncology Group | 190 | 2024-10-15 | 2026-02-27 |
Carcinoma (1) · Carcinoma, Non-Small-Cell Lung (1) · Depressive Disorder (1) · Head and Neck Neoplasms (1) · Hypopharyngeal Neoplasms (1) · Laryngeal Neoplasms (1) · Mouth Neoplasms (1) · Oropharyngeal Neoplasms (1)
Alan Davis (1) · Children's Oncology Group (1) · Mayo Clinic (1)
United States (3) · Puerto Rico (1)
Alan K Davis, PhD (1) · Jason A Mendoza (1) · Katharine A. Price, MD (1)
R01CA274450 (1), UG1CA189955 (1)